T. Rowe Price Health Care ETF Rating $27.79 +0.09 (+0.32%) As of 10/14/2025 03:06 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsRatingsTrendsBuy This Stock T. Rowe Price Health Care ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.TMED Aggregate RatingModerate Buy 2.68Holdings in TMED have an aggregate rating of Moderate Buy based on 510 analyst ratings issued in the past year covering 25 companies (71.9% of the portfolio).TMED Aggregate Price Target$27.79High Prediction$27.79Average Prediction$27.79Low Prediction$27.79Holdings in TMED have an aggregate price target of $27.79 and a range of $27.79 to $27.79 covering 25 companies (71.9% of the portfolio).TMED Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy20 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by T. Rowe Price Health Care ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 TMED Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings14.20%LLYEli Lilly and Company$812.65-0.8%4.9993 of 5 stars2.68$948.06 16.7%25Trending NewsAnalyst UpgradeAnalyst Revision7.92%UNHUnitedHealth Group$359.70+0.3%4.8329 of 5 stars2.46$384.09 6.8%28Positive NewsAnalyst Forecast5.67%ABBVAbbVie$229.19-0.5%4.6135 of 5 stars2.71$231.90 1.2%28Trending NewsAnalyst DowngradeOptions VolumeAnalyst Revision4.79%ABTAbbott Laboratories$133.17+1.4%4.9571 of 5 stars2.91$146.17 9.8%22Positive NewsUpcoming EarningsAnalyst Forecast3.57%DHRDanaher$206.19+0.5%4.9789 of 5 stars2.74$244.60 18.6%23Trending NewsUpcoming Earnings3.55%ISRGIntuitive Surgical$436.39+0.2%4.9426 of 5 stars2.57$585.71 34.2%23Trending NewsUpcoming EarningsAnalyst Forecast3.41%GILDGilead Sciences$118.48+0.2%4.8867 of 5 stars2.86$118.08 -0.3%29Positive News3.37%BDXBecton, Dickinson and Company$188.31+0.9%4.9477 of 5 stars2.25$205.40 9.1%12Positive News2.53%ELANElanco Animal Health$20.25+1.0%2.7755 of 5 stars2.91$19.14 -5.4%112.51%CYTKCytokinetics$61.03+2.4%3.6854 of 5 stars2.76$76.64 25.6%171.89%CVSCVS Health$79.67+1.6%4.8773 of 5 stars2.92$81.05 1.7%26Trending NewsAnalyst ForecastAnalyst Revision1.87%REGNRegeneron Pharmaceuticals$572.60+2.7%4.7625 of 5 stars2.79$817.88 42.8%29Trending NewsAnalyst ForecastAnalyst Revision1.74%AAgilent Technologies$138.12-0.1%4.1118 of 5 stars2.67$149.62 8.3%15Analyst Forecast1.59%ASNDAscendis Pharma A/S$208.71+0.1%3.1412 of 5 stars2.88$248.29 19.0%16News CoverageAnalyst Forecast1.51%ACLXArcellx$87.33+1.3%2.1797 of 5 stars2.87$112.69 29.0%15Analyst Revision1.38%EWEdwards Lifesciences$73.39+0.6%4.9172 of 5 stars2.68$87.06 18.6%25Positive News1.28%TMOThermo Fisher Scientific$525.08+0.1%4.9013 of 5 stars2.71$589.10 12.2%21Positive NewsAnalyst Downgrade1.26%CORCencora$317.86+0.3%4.4277 of 5 stars2.75$320.00 0.7%12Positive NewsAnalyst Downgrade1.23%MCKMcKesson$782.07+1.6%4.8497 of 5 stars2.88$834.54 6.7%17Positive NewsAnalyst Forecast1.21%BIIBBiogen$145.31+0.4%4.6701 of 5 stars2.32$180.69 24.3%31Analyst ForecastAnalyst Revision1.17%HUMHumana$261.19-3.6%4.6717 of 5 stars2.30$297.58 13.9%20Trending NewsAnalyst Forecast1.16%IMTXImmatics$10.17+0.8%2.6162 of 5 stars2.57$13.67 34.4%71.15%MTDMettler-Toledo International$1,302.16+1.4%3.9952 of 5 stars2.42$1,336.50 2.6%12Positive News1.00%DXCMDexCom$66.21+1.5%4.9346 of 5 stars2.87$97.42 47.1%230.96%MDTMedtronic$96.56+1.0%4.8526 of 5 stars2.57$102.41 6.1%23Positive News This page (NASDAQ:TMED) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding T. Rowe Price Health Care ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share T. Rowe Price Health Care ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
